Biosolution Co.Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 2.23x

Biosolution Co.Ltd cash flow reinvestment rate. Biosolution Co.Ltd (086820) has a Cash Flow Reinvestment Rate of 2.23x as of September 2025, reinvesting ₩38.75 Million (capex ₩22.15 Million plus investments ₩16.60 Million) from operating cash flow of ₩17.41 Million. See 086820 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

2.23x
(Capex + Investments) / Operating CF

Total Reinvested

₩38.75 Million
Capex + Investments

Operating Cash Flow

₩17.41 Million
KRW

Capital Expenditures

₩22.15 Million
KRW

Cash Flow Reinvestment Rate of Biosolution Co.Ltd (2018–2023)

Cash flow reinvestment rate of Biosolution Co.Ltd from 2018 to 2023. Historical reinvestment intensity for Biosolution Co.Ltd across 3 annual periods. Explore debt repayment capacity of Biosolution Co.Ltd to assess how comfortably operating cash covers total debt obligations.

Biosolution Co.Ltd Cash Flow Reinvestment Rate by Year (2018–2023)

Biosolution Co.Ltd cash flow reinvestment rate by year from 2018 to 2023. Year-by-year capital reinvestment analysis for Biosolution Co.Ltd. For the full cash flow conversion analysis, see Biosolution Co.Ltd cash conversion from operations.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2023 5.02x ₩10.85 Billion ₩2.16 Billion ₩1.16 Billion ▼ -97.7%
2021 214.45x ₩17.86 Billion ₩83.29 Million ₩663.15 Million ▲ +411.1%
2018 41.96x ₩43.06 Billion ₩1.03 Billion ₩707.50 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow